SEC Form 4 · accession 0001127602-17-003368

AMGEN INC · AMGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Operations

Period of report

Jan 30, 2017

Accepted (ET)

Feb 1, 2017 · 4:57 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000318154

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jan 30, 2017	F	140	$157.16	D	28,223	D
Common Stock^F1,F2	Jan 31, 2017	F	152	$154.43	D	28,071	D
Common Stock^F3	holding	—	—		—	685	I	401K Plan

No Table II lines on this filing.

F1These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 334 RSUs which vest fully in one installment on 4/26/2017; 1,122 RSUs which vest fully in one installment on 8/2/17; 372 RSUs which vest fully in one installment on 1/31/2018; 616 RSUs which vest in one installment of 303 on 1/30/2018 and one installment of 313 on 1/30/2019; 1,023 RSUs which vest in two equal installments of 337 on 5/3/2018 and 5/3/2019 and one installment of 348 on 5/3/2020; and 11,483 RSUS which vest vest in two equal installments of 3,789 on 8/1/2018 and 8/1/2019 and one installment of 3,905 on 8/1/2020. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2These shares include 336 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
F3These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.